Short interest in Viridian Therapeutics Inc (NASDAQ:VRDN) decreased during the last reporting period, falling from 11.63M to 10.88M. This put 15.6% of the company's publicly available shares short.

Short interest for Viridian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Viridian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 924.70K shares traded per day, it would take 11.77 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.